Showcasing Novel Pharmacology & Translational Aspects of SOT106 Targeting LRRC15 in Solid Tumors

• Describing pharmacological characterization of SOT106, including LRRC15 expression within different cell populations in the TME with emphasis on pivotal role in tumor biology
• Developing SOT106 diagnostic antibody tailored to optimize patient selection to identify those who could benefit from therapy
• Exploring the potential of SOT106 combination therapies and how these approaches can elevate its full therapeutic potential